HashiCorp Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
HashiCorp is forecast to grow earnings and revenue by 16.9% and 13.2% per annum respectively. EPS is expected to grow by 6.5% per annum. Return on equity is forecast to be 8.9% in 3 years.
Wichtige Informationen
16.9%
Wachstumsrate der Gewinne
6.5%
EPS-Wachstumsrate
| Software Gewinnwachstum | 16.8% |
| Wachstumsrate der Einnahmen | 13.2% |
| Zukünftige Eigenkapitalrendite | 8.9% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 16 Sep 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
HashiCorp: IBM's Big Deal? Cash In Now
Apr 25What HashiCorp, Inc.'s (NASDAQ:HCP) P/S Is Not Telling You
Apr 23
HashiCorp: Path To Growth Acceleration Is Still Intact
Mar 21Are HashiCorp, Inc. (NASDAQ:HCP) Investors Paying Above The Intrinsic Value?
Mar 06Is HashiCorp, Inc. (NASDAQ:HCP) Potentially Undervalued?
Feb 01HashiCorp Gets A Pass From Me
Jan 28Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 1/31/2027 | 880 | -67 | 68 | 149 | 6 |
| 1/31/2026 | 759 | -130 | 71 | 84 | 18 |
| 1/31/2025 | 664 | -150 | 47 | 58 | 9 |
| 7/31/2024 | 628 | -149 | 27 | 39 | N/A |
| 4/30/2024 | 606 | -189 | 2 | 13 | N/A |
| 1/31/2024 | 583 | -191 | -23 | -11 | N/A |
| 10/31/2023 | 563 | -208 | -31 | -20 | N/A |
| 7/31/2023 | 542 | -241 | -55 | -43 | N/A |
| 4/30/2023 | 513 | -249 | -77 | -67 | N/A |
| 1/31/2023 | 476 | -274 | -93 | -84 | N/A |
| 10/31/2022 | 437 | -453 | -101 | -93 | N/A |
| 7/31/2022 | 394 | -403 | -108 | -101 | N/A |
| 4/30/2022 | 355 | -353 | -79 | -72 | N/A |
| 1/31/2022 | 321 | -290 | -63 | -56 | N/A |
| 10/31/2021 | 286 | -69 | -62 | -56 | N/A |
| 7/31/2021 | 259 | -57 | -46 | -41 | N/A |
| 4/30/2021 | 231 | -65 | -31 | -25 | N/A |
| 1/31/2021 | 212 | -84 | -47 | -40 | N/A |
| 1/31/2020 | 121 | -53 | -29 | -28 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: HCP is forecast to remain unprofitable over the next 3 years.
Ertrag vs. Markt: HCP is forecast to remain unprofitable over the next 3 years.
Hohe Wachstumserträge: HCP is forecast to remain unprofitable over the next 3 years.
Einnahmen vs. Markt: HCP's revenue (13.2% per year) is forecast to grow faster than the US market (8.9% per year).
Hohe Wachstumseinnahmen: HCP's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: HCP's Return on Equity is forecast to be low in 3 years time (8.9%).